Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 4/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7054962 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL3937150 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL3841887 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL39257 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL15637714 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL4992798 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL5825896 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL414800 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL23248621 | 0.92 | CA2 (0.37) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL8660403 | 0.92 | CA2 (0.37) | CA2CA4TDP1SMN1; SMN2GGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136488-A1 | Extended- and Multimodal-Release Compositions | Finoric LLC | 2025-05-01 | — | — | US | claimed |
| US-20250136488-A1 | Extended- and Multimodal-Release Compositions | Finoric LLC | 2025-05-01 | — | — | US | disclosed |